METHODS	Patients were randomised to one of two DES ( Cypher , n = 264 ; Taxus , n = 281 ) or to a cobalt-chromium-based BMS ( Vision , n = 281 ) and followed up for 6 months for occurrence of major adverse cardiac events and costs .\